SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Stericycle, Inc. (SRCL) , forward earnings yield 5.65%. PEG 1.38.
Criteria proven by this page:
- VALUE (35/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 17.7
- PEG Ratio 1.38 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Analyst consensus target $56.33 (-9.1% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 32/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SRCL
Valuation Multiples
P/E (TTM)0.0
Forward P/E17.7
PEG Ratio1.38
Forward PEG1.38
P/B Ratio0.00
P/S Ratio2.15
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.23
Forward EPS (Est.)$3.50
Book Value / Share$0.00
Revenue / Share$28.78
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield5.65%
Dividend Yield0.00%
Analyst Target$56.33 (-9.1%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$3.79 |
$2.56B |
$326.46M |
12.8% |
| 2015 |
$2.96 |
$2.99B |
$267.08M |
8.9% |
| 2016 |
$2.08 |
$3.56B |
$205.97M |
5.8% |
| 2017 |
$0.27 |
$3.58B |
$42.4M |
1.2% |
| 2018 |
$-2.81 |
$3.49B |
$-244.7M |
-7% |
| 2019 |
$-3.80 |
$3.31B |
$-346M |
-10.5% |
| 2020 |
$-0.61 |
$2.68B |
$-55.9M |
-2.1% |
| 2021 |
$-0.29 |
$2.65B |
$-26.8M |
-1% |
| 2022 |
$0.61 |
$2.7B |
$56M |
2.1% |
| 2023 |
$-0.23 |
$2.66B |
$-21.4M |
-0.8% |
